Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Lung inflammatory injury and tissue repair (Jul 2023)
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Endothelial transplantation rejuvenates aged hematopoietic stem cell function
Michael G. Poulos, … , Sina Y. Rabbany, Jason M. Butler
Michael G. Poulos, … , Sina Y. Rabbany, Jason M. Butler
Published October 16, 2017
Citation Information: J Clin Invest. 2017;127(11):4163-4178. https://doi.org/10.1172/JCI93940.
View: Text | PDF
Concise Communication Stem cells Transplantation

Endothelial transplantation rejuvenates aged hematopoietic stem cell function

  • Text
  • PDF
Abstract

Age-related changes in the hematopoietic compartment are primarily attributed to cell-intrinsic alterations in hematopoietic stem cells (HSCs); however, the contribution of the aged microenvironment has not been adequately evaluated. Understanding the role of the bone marrow (BM) microenvironment in supporting HSC function may prove to be beneficial in treating age-related functional hematopoietic decline. Here, we determined that aging of endothelial cells (ECs), a critical component of the BM microenvironment, was sufficient to drive hematopoietic aging phenotypes in young HSCs. We used an ex vivo hematopoietic stem and progenitor cell/EC (HSPC/EC) coculture system as well as in vivo EC infusions following myelosuppressive injury in mice to demonstrate that aged ECs impair the repopulating activity of young HSCs and impart a myeloid bias. Conversely, young ECs restored the repopulating capacity of aged HSCs but were unable to reverse the intrinsic myeloid bias. Infusion of young, HSC-supportive BM ECs enhanced hematopoietic recovery following myelosuppressive injury and restored endogenous HSC function in aged mice. Coinfusion of young ECs augmented aged HSC engraftment and enhanced overall survival in lethally irradiated mice by mitigating damage to the BM vascular microenvironment. These data lay the groundwork for the exploration of EC therapies that can serve as adjuvant modalities to enhance HSC engraftment and accelerate hematopoietic recovery in the elderly population following myelosuppressive regimens.

Authors

Michael G. Poulos, Pradeep Ramalingam, Michael C. Gutkin, Pierre Llanos, Katherine Gilleran, Sina Y. Rabbany, Jason M. Butler

×

Figure 6

Young EC coinfusion radioprotects the BM microenvironment.

Options: View larger image (or click on image) Download as PowerPoint
Young EC coinfusion radioprotects the BM microenvironment.
Lethally irra...
Lethally irradiated (9.50 Gy) mice were coinfused with either 105 young or aged WBM cells and 5 × 105 young BM ECs. (A) Representative H&E-stained longitudinal femur sections from coinfused mice 7 days after irradiation (n = 10 mice/cohort). Original magnification, ×100. (B) Representative images of damaged VEGFR3+ femoral vessels, including type I hemorrhagic (asterisk), type I discontinuous (red arrow), and type II regressed (blue arrow), 7 days after irradiation, demonstrating radioprotection of the vascular niche (n = 10 mice/cohort). Sections were counterstained with hematoxylin. Original magnification, ×200. (C and D) Quantification of total BM CD45+ cells showing mitigation of panhematopoietic injury in cohorts coinfused with young or aged WBM and young ECs (n = 10 mice/cohort; data are related to A). (E and F) Quantification of type I/II damaged VEGFR3+ sinusoidal vessels in cohorts coinfused with young or aged WBM and young ECs (n = 10 mice/cohort; data are related to B). Error bars represent the sample mean ± SEM. ***P < 0.001, by unpaired, 2-tailed Student’s t test. Steady-state controls were used as a reference point and were not included in the statistical analysis.

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts